Skip to main content
Top
Published in: Journal of the International Society of Sports Nutrition 1/2014

Open Access 01-12-2014 | Research article

Quercetin intake with exercise modulates lipoprotein metabolism and reduces atherosclerosis plaque formation

Authors: Mahdi Garelnabi, Halleh Mahini, Thomas Wilson

Published in: Journal of the International Society of Sports Nutrition | Issue 1/2014

Login to get access

Abstract

Study objectives

We proposed that mice supplemented with quercetin, a class of flavonoids known to have antioxidant and anti-inflammatory properties, will have profound effects on the pathophysiology of atherosclerosis when combined with exercise.

Study design

Forty C57BL6 LDLr −/− mice were divided into four groups (n = 10): control untreated (NN); control group supplemented with 100 μg/day of quercetin (NQ); exercise group (EN); and exercise group supplemented with 100 μg/day of quercetin (EQ). All animals were fed atherogenic diet. The exercise groups were run on a treadmill for 30 minutes, 15 m/min for 5 days/week for 30 days. After 30 day animals were sacrificed and tissues were harvested.

Results and conclusion

Mice supplemented with quercetin during exercise sessions had 78% atherosclerotic plaque reduction compared to control mice and 40% less atherosclerotic plaque formation compared to control group supplemented with quercetin. The manifestation of the combination of quercetin supplementation with exercise was more evident in the pro-reverse cholesterol transport genes, indicating a plausible mechanism for their combined beneficial effect.
The pathogenesis of atherosclerosis, the major cause of cardiovascular diseases (CVD), is multifactorial and therefore its treatment approaches and the ability to regress the plaque are complicated. Data from research on animal models and clinical studies have indicated that moderate daily exercise can alleviate the risk for the development of atherosclerotic plaques, while the same has not been true for the supplementation of antioxidants.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hansson GK, Robertson AK, Söderberg-Nauclér C: Inflammation and atherosclerosis. Annu Rev Pathol. 2006, 1: 297-329. 10.1146/annurev.pathol.1.110304.100100.CrossRefPubMed Hansson GK, Robertson AK, Söderberg-Nauclér C: Inflammation and atherosclerosis. Annu Rev Pathol. 2006, 1: 297-329. 10.1146/annurev.pathol.1.110304.100100.CrossRefPubMed
2.
go back to reference Wool GD, Reardon CA: The influence of acute phase proteins on murine atherosclerosis. Curr Drug Targets. 2007, 8 (11): 1203-1214. 10.2174/138945007782403856.CrossRefPubMed Wool GD, Reardon CA: The influence of acute phase proteins on murine atherosclerosis. Curr Drug Targets. 2007, 8 (11): 1203-1214. 10.2174/138945007782403856.CrossRefPubMed
3.
go back to reference Garelnabi M: Emerging evidences from the contribution of the traditional and new risk factors to the atherosclerosis pathogenesis. J Med Sci. 2010, 10: 153-161.CrossRef Garelnabi M: Emerging evidences from the contribution of the traditional and new risk factors to the atherosclerosis pathogenesis. J Med Sci. 2010, 10: 153-161.CrossRef
4.
go back to reference Parthasarathy S, Litvinov D, Selvarajan K, Garelnabi M: Lipid peroxidation and decomposition–conflicting roles in plaque vulnerability and stability. Biochim Biophys Acta. 2008, 1781 (5): 221-231. 10.1016/j.bbalip.2008.03.002.PubMedCentralCrossRefPubMed Parthasarathy S, Litvinov D, Selvarajan K, Garelnabi M: Lipid peroxidation and decomposition–conflicting roles in plaque vulnerability and stability. Biochim Biophys Acta. 2008, 1781 (5): 221-231. 10.1016/j.bbalip.2008.03.002.PubMedCentralCrossRefPubMed
5.
go back to reference Tobias PS, Curtiss LK: Toll-like receptors in atherosclerosis. Biochem Soc Trans. 2007, 35 (Pt 6): 1453-1455.CrossRefPubMed Tobias PS, Curtiss LK: Toll-like receptors in atherosclerosis. Biochem Soc Trans. 2007, 35 (Pt 6): 1453-1455.CrossRefPubMed
6.
go back to reference Litvinov D, Mahini H, Garelnabi M: Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci. 2012, 4 (11): 523-532. 10.4103/1947-2714.103310.PubMedCentralCrossRefPubMed Litvinov D, Mahini H, Garelnabi M: Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci. 2012, 4 (11): 523-532. 10.4103/1947-2714.103310.PubMedCentralCrossRefPubMed
7.
go back to reference Ohashi K, Ouchi N, Matsuzawa Y: Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 2012, 94 (10): 2137-2142. 10.1016/j.biochi.2012.06.008.CrossRefPubMed Ohashi K, Ouchi N, Matsuzawa Y: Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 2012, 94 (10): 2137-2142. 10.1016/j.biochi.2012.06.008.CrossRefPubMed
8.
go back to reference Paccou J, Brazier M, Mentaverri R, Kamel S, Fardellone P, Massy ZA: Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets. Atherosclerosis. 2012, 224 (2): 283-290. 10.1016/j.atherosclerosis.2012.04.008.CrossRefPubMed Paccou J, Brazier M, Mentaverri R, Kamel S, Fardellone P, Massy ZA: Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets. Atherosclerosis. 2012, 224 (2): 283-290. 10.1016/j.atherosclerosis.2012.04.008.CrossRefPubMed
9.
go back to reference Ansell BJ: Targeting the anti-inflammatory effects of high-density lipoprotein. Am J Cardio. 2007, 100 (11 A): n3-n9.CrossRef Ansell BJ: Targeting the anti-inflammatory effects of high-density lipoprotein. Am J Cardio. 2007, 100 (11 A): n3-n9.CrossRef
10.
go back to reference Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N: Oxidized low-density lipoprotein. Methods Mol Biol. 2010, 610: 403-417. 10.1007/978-1-60327-029-8_24.PubMedCentralCrossRefPubMed Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N: Oxidized low-density lipoprotein. Methods Mol Biol. 2010, 610: 403-417. 10.1007/978-1-60327-029-8_24.PubMedCentralCrossRefPubMed
11.
go back to reference Rosenson RS, Stafforini DM: Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2. J Lipid Res. 2012, 53 (9): 1767-1782. 10.1194/jlr.R024190.PubMedCentralCrossRefPubMed Rosenson RS, Stafforini DM: Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2. J Lipid Res. 2012, 53 (9): 1767-1782. 10.1194/jlr.R024190.PubMedCentralCrossRefPubMed
12.
go back to reference Dietz P, Hoffmann S, Lachtermann E, Simon P: Influence of exclusive resistance training on body composition and cardiovascular risk factors in overweight or obese children: a systematic review. Obes Facts. 2012, 5 (4): 546-560. 10.1159/000341560.CrossRefPubMed Dietz P, Hoffmann S, Lachtermann E, Simon P: Influence of exclusive resistance training on body composition and cardiovascular risk factors in overweight or obese children: a systematic review. Obes Facts. 2012, 5 (4): 546-560. 10.1159/000341560.CrossRefPubMed
13.
go back to reference Leung FP, Yung LM, Laher I, Yao X, Chen ZY, Huang Y: Exercise, vascular wall and cardiovascular diseases: an update (Part 1). Sports Med. 2008, 38 (12): 1009-1024. 10.2165/00007256-200838120-00005.CrossRefPubMed Leung FP, Yung LM, Laher I, Yao X, Chen ZY, Huang Y: Exercise, vascular wall and cardiovascular diseases: an update (Part 1). Sports Med. 2008, 38 (12): 1009-1024. 10.2165/00007256-200838120-00005.CrossRefPubMed
14.
go back to reference Heckman GA, McKelvie RS: Cardiovascular aging and exercise in healthy older adults. Clin J Sport Med. 2008, 18 (6): 479-485. 10.1097/JSM.0b013e3181865f03.CrossRefPubMed Heckman GA, McKelvie RS: Cardiovascular aging and exercise in healthy older adults. Clin J Sport Med. 2008, 18 (6): 479-485. 10.1097/JSM.0b013e3181865f03.CrossRefPubMed
15.
go back to reference Garelnabi M, Veledar E, White-Welkley J, Santanam N, Abramson J, Weintraub W, Parthasarathy S: Vitamin E differentially affects short term exercise induced changes in oxidative stress, lipids, and inflammatory markers. Nutr Metab Cardiovasc Dis. 2012, 22 (10): 907-913. 10.1016/j.numecd.2011.03.002.PubMedCentralCrossRefPubMed Garelnabi M, Veledar E, White-Welkley J, Santanam N, Abramson J, Weintraub W, Parthasarathy S: Vitamin E differentially affects short term exercise induced changes in oxidative stress, lipids, and inflammatory markers. Nutr Metab Cardiovasc Dis. 2012, 22 (10): 907-913. 10.1016/j.numecd.2011.03.002.PubMedCentralCrossRefPubMed
16.
go back to reference Garelnabi M, Veledar E, Abramson J, White-Welkley J, Santanam N, Weintraub W, Parthasarathy S: Physical inactivity and cardiovascular risk: baseline observations from men and premenopausal women. J Clin Lab Anal. 2010, 24 (2): 100-105. 10.1002/jcla.20368.CrossRefPubMed Garelnabi M, Veledar E, Abramson J, White-Welkley J, Santanam N, Weintraub W, Parthasarathy S: Physical inactivity and cardiovascular risk: baseline observations from men and premenopausal women. J Clin Lab Anal. 2010, 24 (2): 100-105. 10.1002/jcla.20368.CrossRefPubMed
17.
go back to reference Siebel AL, Carey AL, Kingwell BA: Can exercise training rescue the adverse cardiometabolic effects of low birth weight and prematurity?. Clin Exp Pharmacol Physiol. 2012, 39 (11): 944-957. 10.1111/j.1440-1681.2012.05732.x.CrossRefPubMed Siebel AL, Carey AL, Kingwell BA: Can exercise training rescue the adverse cardiometabolic effects of low birth weight and prematurity?. Clin Exp Pharmacol Physiol. 2012, 39 (11): 944-957. 10.1111/j.1440-1681.2012.05732.x.CrossRefPubMed
18.
go back to reference Fernandes-Silva MM, Carvalho VO, Guimarães GV, Bacal F, Bocchi EA: Physical exercise and microRNAs: new frontiers in heart failure. Arq Bras Cardiol. 2012, 98 (5): 459-466. 10.1590/S0066-782X2012000500012.CrossRefPubMed Fernandes-Silva MM, Carvalho VO, Guimarães GV, Bacal F, Bocchi EA: Physical exercise and microRNAs: new frontiers in heart failure. Arq Bras Cardiol. 2012, 98 (5): 459-466. 10.1590/S0066-782X2012000500012.CrossRefPubMed
19.
go back to reference Wei C, Penumetcha M, Santanam N, Liu YG, Garelnabi M, Parthasarathy S: Exercise might favor reverse cholesterol transport and lipoprotein clearance: potential mechanism for its anti-atherosclerotic effects. Biochim Biophys Acta. 2005, 1723 (1–3): 124-127.CrossRefPubMed Wei C, Penumetcha M, Santanam N, Liu YG, Garelnabi M, Parthasarathy S: Exercise might favor reverse cholesterol transport and lipoprotein clearance: potential mechanism for its anti-atherosclerotic effects. Biochim Biophys Acta. 2005, 1723 (1–3): 124-127.CrossRefPubMed
20.
go back to reference Cesar L, Vasallo Suarez S, Adi J, Adi N, Vazquez-Padron R, Yu H, Ma Q, Goldschmidt-Clermont PJ, Agatston A, Kurlansky P, Webster KA: An essential role for diet in exercise-mediated protection against dyslipidemia, inflammation and atherosclerosis in ApoE−/− mice. PLoS One. 2011, 6 (2): e17263-10.1371/journal.pone.0017263.PubMedCentralCrossRefPubMed Cesar L, Vasallo Suarez S, Adi J, Adi N, Vazquez-Padron R, Yu H, Ma Q, Goldschmidt-Clermont PJ, Agatston A, Kurlansky P, Webster KA: An essential role for diet in exercise-mediated protection against dyslipidemia, inflammation and atherosclerosis in ApoE−/− mice. PLoS One. 2011, 6 (2): e17263-10.1371/journal.pone.0017263.PubMedCentralCrossRefPubMed
21.
go back to reference Wen S, Jadhav KS, Williamson DL, Rideout TC: Treadmill exercise training modulates hepatic cholesterol metabolism and circulating PCSK9 concentration in high-Fat-Fed mice. J Lipids. 2013, 2013: 908048-doi:10.1155/2013/908048. Epub 2013 Jun 19, PubMed PMID: 23862065PubMedCentralCrossRefPubMed Wen S, Jadhav KS, Williamson DL, Rideout TC: Treadmill exercise training modulates hepatic cholesterol metabolism and circulating PCSK9 concentration in high-Fat-Fed mice. J Lipids. 2013, 2013: 908048-doi:10.1155/2013/908048. Epub 2013 Jun 19, PubMed PMID: 23862065PubMedCentralCrossRefPubMed
22.
go back to reference Ramachandran S, Penumetcha M, Merchant NK, Santanam N, Rong R, Parthasarathy S: Exercise reduces preexisting atherosclerotic lesions in LDL receptor knockout mice. Atherosclerosis. 2005, 178 (1): 33-38. 10.1016/j.atherosclerosis.2004.08.010.CrossRefPubMed Ramachandran S, Penumetcha M, Merchant NK, Santanam N, Rong R, Parthasarathy S: Exercise reduces preexisting atherosclerotic lesions in LDL receptor knockout mice. Atherosclerosis. 2005, 178 (1): 33-38. 10.1016/j.atherosclerosis.2004.08.010.CrossRefPubMed
23.
go back to reference Meilhac O, Ramachandran S, Chiang K, Santanam N, Parthasarathy S: Role of arterial wall antioxidant defense in beneficial effects of exercise on atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2001, 21 (10): 1681-1688. 10.1161/hq1001.097106.CrossRefPubMed Meilhac O, Ramachandran S, Chiang K, Santanam N, Parthasarathy S: Role of arterial wall antioxidant defense in beneficial effects of exercise on atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2001, 21 (10): 1681-1688. 10.1161/hq1001.097106.CrossRefPubMed
24.
go back to reference Yang T, Luo F, Shen Y, An J, Li X, Liu X, Ying B, Liao Z, Dong J, Guo L, Wang T, Xu D, Chen L, Wen F: Quercetin attenuates airway inflammation and mucus production induced by cigarette smoke in rats. Int Immunopharmacol. 2012, 13 (1): 73-81. 10.1016/j.intimp.2012.03.006.CrossRefPubMed Yang T, Luo F, Shen Y, An J, Li X, Liu X, Ying B, Liao Z, Dong J, Guo L, Wang T, Xu D, Chen L, Wen F: Quercetin attenuates airway inflammation and mucus production induced by cigarette smoke in rats. Int Immunopharmacol. 2012, 13 (1): 73-81. 10.1016/j.intimp.2012.03.006.CrossRefPubMed
25.
go back to reference Boly R, Gras T, Lamkami T, Guissou P, Serteyn D, Kiss R, Dubois J: Quercetin inhibits a large panel of kinases implicated in cancer cell biology. Int J Oncol. 2011, 38 (3): 833-842.PubMed Boly R, Gras T, Lamkami T, Guissou P, Serteyn D, Kiss R, Dubois J: Quercetin inhibits a large panel of kinases implicated in cancer cell biology. Int J Oncol. 2011, 38 (3): 833-842.PubMed
26.
go back to reference Wang G, Wang JJ, Chen XL, Du SM, Li DS, Pei ZJ, Lan H, Wu LB: The JAK2/STAT3 and mitochondrial pathways are essential for quercetin nanoliposome-induced C6 glioma cell death. Cell Death Dis. 2013, 4: e746-10.1038/cddis.2013.242. doi:10.1038/cddis.2013.242. PubMed PMID: 23907460PubMedCentralCrossRefPubMed Wang G, Wang JJ, Chen XL, Du SM, Li DS, Pei ZJ, Lan H, Wu LB: The JAK2/STAT3 and mitochondrial pathways are essential for quercetin nanoliposome-induced C6 glioma cell death. Cell Death Dis. 2013, 4: e746-10.1038/cddis.2013.242. doi:10.1038/cddis.2013.242. PubMed PMID: 23907460PubMedCentralCrossRefPubMed
27.
go back to reference Michaud-Levesque J, Bousquet-Gagnon N, Béliveau R: Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Exp Cell Res. 2012, 318 (8): 925-935. 10.1016/j.yexcr.2012.02.017.CrossRefPubMed Michaud-Levesque J, Bousquet-Gagnon N, Béliveau R: Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Exp Cell Res. 2012, 318 (8): 925-935. 10.1016/j.yexcr.2012.02.017.CrossRefPubMed
28.
go back to reference Song Y, Liu J, Zhang F, Zhang J, Shi T, Zeng Z: Antioxidant effect of quercetin against acute spinal cord injury in rats and its correlation with the p38MAPK/iNOS signaling pathway. Life Sci. 2013, 92 (24–26): 1215-1221.CrossRefPubMed Song Y, Liu J, Zhang F, Zhang J, Shi T, Zeng Z: Antioxidant effect of quercetin against acute spinal cord injury in rats and its correlation with the p38MAPK/iNOS signaling pathway. Life Sci. 2013, 92 (24–26): 1215-1221.CrossRefPubMed
29.
go back to reference Jung CH, Cho I, Ahn J, Jeon TI, Ha TY: Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother Res. 2013, 27 (1): 139-143. 10.1002/ptr.4687.CrossRefPubMed Jung CH, Cho I, Ahn J, Jeon TI, Ha TY: Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother Res. 2013, 27 (1): 139-143. 10.1002/ptr.4687.CrossRefPubMed
30.
go back to reference Chang YC, Lee TS, Chiang AN: Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages. J Lipid Res. 2012, 53 (9): 1840-1850. 10.1194/jlr.M024471.PubMedCentralCrossRefPubMed Chang YC, Lee TS, Chiang AN: Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages. J Lipid Res. 2012, 53 (9): 1840-1850. 10.1194/jlr.M024471.PubMedCentralCrossRefPubMed
31.
go back to reference Litvinov D, Selvarajan K, Garelnabi M, Brophy L, Parthasarathy S: Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice. Atherosclerosis. 2010, 209 (2): 449-454. 10.1016/j.atherosclerosis.2009.09.076.PubMedCentralCrossRefPubMed Litvinov D, Selvarajan K, Garelnabi M, Brophy L, Parthasarathy S: Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice. Atherosclerosis. 2010, 209 (2): 449-454. 10.1016/j.atherosclerosis.2009.09.076.PubMedCentralCrossRefPubMed
32.
go back to reference Thijssen DH, Cable NT, Green DJ: Impact of exercise training on arterial wall thickness in humans. Clin Sci (Lond). 2012, 122 (7): 311-322. 10.1042/CS20110469.CrossRef Thijssen DH, Cable NT, Green DJ: Impact of exercise training on arterial wall thickness in humans. Clin Sci (Lond). 2012, 122 (7): 311-322. 10.1042/CS20110469.CrossRef
33.
go back to reference Rankin AJ, Rankin AC, MacIntyre P, Hillis WS: Walk or run? Is high-intensity exercise more effective than moderate-intensity exercise at reducing cardiovascular risk?. Scott Med J. 2012, 57 (2): 99-102. 10.1258/smj.2011.011284.CrossRefPubMed Rankin AJ, Rankin AC, MacIntyre P, Hillis WS: Walk or run? Is high-intensity exercise more effective than moderate-intensity exercise at reducing cardiovascular risk?. Scott Med J. 2012, 57 (2): 99-102. 10.1258/smj.2011.011284.CrossRefPubMed
34.
go back to reference Bowles DK, Laughlin MH: Mechanism of beneficial effects of physical activity on atherosclerosis and coronary heart disease. J Appl Physiol. 2011, 111 (1): 308-310. 10.1152/japplphysiol.00634.2011.PubMedCentralCrossRefPubMed Bowles DK, Laughlin MH: Mechanism of beneficial effects of physical activity on atherosclerosis and coronary heart disease. J Appl Physiol. 2011, 111 (1): 308-310. 10.1152/japplphysiol.00634.2011.PubMedCentralCrossRefPubMed
35.
go back to reference Namiki M, Kawashima S, Yamashita T, Ozaki M, Hirase T, Ishida T, Inoue N, Hirata K, Matsukawa A, Morishita R, Kaneda Y, Yokoyama M: Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2002, 22 (1): 115-120. 10.1161/hq0102.102278.CrossRefPubMed Namiki M, Kawashima S, Yamashita T, Ozaki M, Hirase T, Ishida T, Inoue N, Hirata K, Matsukawa A, Morishita R, Kaneda Y, Yokoyama M: Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2002, 22 (1): 115-120. 10.1161/hq0102.102278.CrossRefPubMed
36.
go back to reference Bereta J, Cohen MC, Bereta M: Stimulatory effect of ouabain on VCAM-1 and iNOS expression in murine endothelial cells: involvement of NF-kappa B. FEBS Lett. 1995, 377 (1): 21-25. 10.1016/0014-5793(95)01301-6.CrossRefPubMed Bereta J, Cohen MC, Bereta M: Stimulatory effect of ouabain on VCAM-1 and iNOS expression in murine endothelial cells: involvement of NF-kappa B. FEBS Lett. 1995, 377 (1): 21-25. 10.1016/0014-5793(95)01301-6.CrossRefPubMed
37.
go back to reference Naderi GA, Asgary S, Sarraf-Zadegan N, Shirvany H: Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Mol Cell Biochem. 2003, 246 (1–2): 193-196.CrossRefPubMed Naderi GA, Asgary S, Sarraf-Zadegan N, Shirvany H: Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Mol Cell Biochem. 2003, 246 (1–2): 193-196.CrossRefPubMed
38.
go back to reference Yao S, Sang H, Song G, Yang N, Liu Q, Zhang Y, Jiao P, Zong C, Qin S: Quercetin protects macrophages from oxidized low-density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress-C/EBP homologous protein pathway. Exp Biol Med (Maywood). 2012, 237 (7): 822-831. 10.1258/ebm.2012.012027.CrossRef Yao S, Sang H, Song G, Yang N, Liu Q, Zhang Y, Jiao P, Zong C, Qin S: Quercetin protects macrophages from oxidized low-density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress-C/EBP homologous protein pathway. Exp Biol Med (Maywood). 2012, 237 (7): 822-831. 10.1258/ebm.2012.012027.CrossRef
39.
go back to reference Suzuki M, Yamamoto M, Sugimoto A, Nakamura S, Motoda R, Orita K: Delta-4 expression on a stromal cell line is augmented by interleukin-6 via STAT3 activation. Exp Hematol. 2006, 34 (9): 1143-1150.CrossRefPubMed Suzuki M, Yamamoto M, Sugimoto A, Nakamura S, Motoda R, Orita K: Delta-4 expression on a stromal cell line is augmented by interleukin-6 via STAT3 activation. Exp Hematol. 2006, 34 (9): 1143-1150.CrossRefPubMed
Metadata
Title
Quercetin intake with exercise modulates lipoprotein metabolism and reduces atherosclerosis plaque formation
Authors
Mahdi Garelnabi
Halleh Mahini
Thomas Wilson
Publication date
01-12-2014
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1550-2783-11-22

Other articles of this Issue 1/2014

Journal of the International Society of Sports Nutrition 1/2014 Go to the issue